Shih-Huan Su
Papers
1
Total Citations
4
H-Index
1
About
Dr. Shih-Huan Su is a urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly those undergoing robotic-assisted radical prostatectomy (RARP). His work centers on identifying clinical predictors of biochemical failure—a key indicator of cancer recurrence—in patients with positive surgical margins after surgery. In his most cited study (2021, 4 citations), Dr. Su systematically analyzed risk factors for biochemical failure in this high-risk population, providing critical insights that help clinicians stratify patients and tailor postoperative surveillance or adjuvant therapy. This contribution addresses a significant clinical challenge, as positive surgical margins are associated with worse oncologic outcomes. By elucidating which patients are most likely to experience recurrence, his research directly informs decision-making in the era of precision medicine for prostate cancer. Dr. Su’s work bridges the gap between surgical technique and long-term cancer control, underscoring his commitment to evidence-based urologic oncology. His findings offer valuable guidance for urologists and oncologists managing post-prostatectomy patients, ultimately aiming to reduce unnecessary treatments while catching recurrences early.
Research Focus
Key Achievements
Top Papers
- 1